Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells

A low concentration of bufalin, a component of bufadienoides in the traditional Chinese medicine chan'su, was shown previously to induce differentiation of a broad range of human leukemia cell lines. In the present study, we found that bufalin at concentrations of 10 −7 M and higher induced apo...

Full description

Saved in:
Bibliographic Details
Published inLeukemia research Vol. 19; no. 8; pp. 549 - 556
Main Authors Masuda, Yutaka, Kawazoe, Nobuko, Nakajo, Shigeo, Yoshida, Takemi, Kuroiwa, Yukio, Nakaya, Kazuyasu
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.08.1995
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A low concentration of bufalin, a component of bufadienoides in the traditional Chinese medicine chan'su, was shown previously to induce differentiation of a broad range of human leukemia cell lines. In the present study, we found that bufalin at concentrations of 10 −7 M and higher induced apoptosis in human leukemia cells, such as HL60, ML1, but not in mouse leukemia M1 cells. A mere 15 min pretreatment of HL60 cells with 10 −6 M bufalin, followed by incubation for 15 h without bufalin, caused fragmentation of DNA and a decrease in cell viability, indicating that the signal for induction of apoptosis is triggered rapidly upon treatment with bufalin. Bufalin-induced apoptosis in HL60 cells was inhibited by ZnCl 2, an inhibitor of endonuclease, but not by cycloheximide, an inhibitor of protein synthesis. Northern blot analysis revealed that the levels of expression of the c-myc and bcl-2 genes in HL60 cells decreased with time after treatment with bufalin. These results suggest that bufalin induces apoptosis specifically in human leukemia cells by altering the expression of these genes involved in apoptosis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0145-2126
1873-5835
DOI:10.1016/0145-2126(95)00031-I